TY - JOUR T1 - Human genomics of the humoral immune response against polyomaviruses JF - medRxiv DO - 10.1101/2020.11.02.20224402 SP - 2020.11.02.20224402 AU - F. Hodel AU - A.Y. Chong AU - P. Scepanovic AU - Z.M. Xu AU - O. Naret AU - C.W. Thorball AU - S. Rüeger AU - P. Marques-Vidal AU - P. Vollenweider AU - M. Begemann AU - H. Ehrenreich AU - N. Brenner AU - N. Bender AU - T. Waterboer AU - A. J. Mentzer AU - A.V.S. Hill AU - C. Hammer AU - J. Fellay Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/04/2020.11.02.20224402.abstract N2 - Human polyomaviruses are widespread in human populations and are able to cause severe disease in immunocompromised individuals. There remains an incomplete understanding of the potential impact of human genetic variation on inter-individual responses to polyomaviruses.To identify human genetic determinants of the humoral immune response against polyomaviruses, we performed genome-wide association studies and meta-analyses of qualitative and quantitative immunoglobulin G (IgG) responses against the major capsid protein VP1 of Human polyomavirus 6 (HPyV6), BK virus (BKPyV), JC virus (JCPyV), Merkel Cell Polyomavirus (MCPyV) and WU polyomavirus (WUPyV), in a total of 15,660 individuals of European ancestry from CoLaus, UK Biobank and GRAS, three independent studies.We observed significant associations for all tested viruses: JCPyV, HPyV6 and MCPyV associated with HLA class II variation; BKPyV and JCPyV with variants in the FUT2 gene, responsible for secretor status; MCPyV with variants in the STING1 gene, involved in interferon induction; and WUPyV with a functional variant in the MUC1 gene, previously associated with risk for gastric cancer.These results provide insights into the genetic control of a family of very prevalent human viruses, highlighting genes and pathways that play a modulating role in human humoral immunity.Competing Interest StatementC.H. is an employee of Genentech Inc., a member of the Roche Group. P.S. is an employee of the Roche Group. The remaining authors declare that they have no competing interests.Funding StatementThis work was supported by the Swiss National Science Foundation, grant #175603 to JF.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The CoLaus study: The institutional Ethics Committee of the University of Lausanne, which afterwards became the Ethics Commission of Canton Vaud (www.cer-vd.ch) approved the baseline CoLaus study (reference 16/03, decisions of 13th January and 10th February 2003), and written consent was obtained from all participants. The GRAS Data Collection: All study participants provided informed consent, including genetic testing, and the GRAS Data Collection has been approved by the ethical committee of the Georg-August-University of Goettingen (master committee) as well as by the respective local regulatory / ethical committees of all collaborating centers. The UK Biobank: This project was conducted with approved access to UKB data under application numbers 50085 (PI: Fellay) and 43920. All UKB participants provided informed consent at recruitment. Ethics approval for the UKB study was obtained from the North West Centre for Research Ethics Committee (11/NW/0382).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFull meta-analyses association results are available for download from Zenodo. https://doi.org/10.5281/zenodo.4189621 ER -